Insider · CIK 0001832203
Reape Kathleen
Reports to the SEC for 1 company · DALLAS, TX
Transactions
4
Companies
1
Filings
4
CIK
0001832203
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-06-22 | TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award | — |
| 2022-06-17 | TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award | — |
| 2021-06-17 | TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award | — |
| 2020-11-23 | TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award | — |
Recent filings
- 4Reape Kathleen0001209191-23-039732SEC(opens sec.gov)
- 4Reape Kathleen0001209191-22-038687SEC(opens sec.gov)
- 4Reape Kathleen0001209191-21-042106SEC(opens sec.gov)
- 4Reape Kathleen0001209191-20-060225SEC(opens sec.gov)
Companies
Address
C/O TAYSHA GENE THERAPIES, INC. 2280 INWOOD ROAD
DALLAS, TX, 75235